Bernard Ravina
2021
In 2021, Bernard Ravina earned a total compensation of $4.5M as Chief Medical Officer at Praxis Precision Medicines, a 164% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $285,000 |
|---|---|
| Option Awards | $2,451,050 |
| Salary | $466,667 |
| Stock Awards | $1,287,616 |
| Other | $18,838 |
| Total | $4,509,171 |
Ravina received $2.5M in option awards, accounting for 54% of the total pay in 2021.
Ravina also received $285K in non-equity incentive plan, $466.7K in salary, $1.3M in stock awards and $18.8K in other compensation.
Rankings
In 2021, Bernard Ravina's compensation ranked 2,940th out of 12,406 executives tracked by ExecPay. In other words, Ravina earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,940 out of 12,406 | 76th |
Division Manufacturing | 1,174 out of 5,494 | 79th |
Major group Chemicals And Allied Products | 469 out of 2,369 | 80th |
Industry group Drugs | 412 out of 2,090 | 80th |
Industry Pharmaceutical Preparations | 278 out of 1,537 | 82nd |
Source: SEC filing on April 14, 2022.
Ravina's colleagues
We found two more compensation records of executives who worked with Bernard Ravina at Praxis Precision Medicines in 2021.